Quantcast
Channel: Todd Pope – BioTuesdays
Browsing all 6 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

SafeStitch and TransEnterix complete merger

SafeStitch Medical (OTCBB:SFES) and closely-held TransEnterix have completed a previously announced merger, with the combined company to be renamed TransEnterix. The company will continue to trade...

View Article



Image may be NSFW.
Clik here to view.

TransEnterix readying FDA filing of SurgiBot in mid-year

TransEnterix (NYSE MKT:TRXC) plans to file for FDA approval in mid-year of its SurgiBot robotic platform to enhance minimally invasive laparoscopic surgery through a single surgical incision. Todd Pope...

View Article

Image may be NSFW.
Clik here to view.

TransEnterix files 510(k) with FDA for SurgiBot

TransEnterix (NYSE MKT:TRXC) has submitted a 510(k) application with the FDA for clearance of the company’s SurgiBot System. ““Robotically enhanced laparoscopy with the SurgiBot System represents the...

View Article

Image may be NSFW.
Clik here to view.

TransEnterix names Paul Ziegler as VP sales

TransEnterix (NYSE MKT:TRXC) has appointed Paul Ziegler as VP of sales, effective August 31. He will report directly to CEO, Todd Pope. Paul Ziegler Most recently, Mr. Ziegler served as regional VP of...

View Article

Image may be NSFW.
Clik here to view.

TransEnterix updates SurgiBot FDA submission

TransEnterix (NYSE MKT:TRXC) has received an update from the FDA on the status of the 510(k) submission for its robotics SurgiBot system to improve minimally invasive surgery. The FDA advised the...

View Article


Image may be NSFW.
Clik here to view.

FDA rejects TransEnterix SurgiBot submission

The FDA has advised TransEnterix (NYSE MKT:TRXC) that its SurgiBot System does not meet the criteria for substantial equivalence based on the data and information submitted by the company in its 510(k)...

View Article
Browsing all 6 articles
Browse latest View live




Latest Images